ES2141085T3 - Analogos del factor liberador de la hormona del crecimiento. - Google Patents

Analogos del factor liberador de la hormona del crecimiento.

Info

Publication number
ES2141085T3
ES2141085T3 ES91303507T ES91303507T ES2141085T3 ES 2141085 T3 ES2141085 T3 ES 2141085T3 ES 91303507 T ES91303507 T ES 91303507T ES 91303507 T ES91303507 T ES 91303507T ES 2141085 T3 ES2141085 T3 ES 2141085T3
Authority
ES
Spain
Prior art keywords
growth hormone
analogs
release factor
compounds
flc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91303507T
Other languages
English (en)
Inventor
Gerald Stephen Brooke
Richard Dennis Dimarchi
Mark Louis Heiman
Hansen Maxwell Hsiung
David Lee Smiley
Dennis Paul Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2141085T3 publication Critical patent/ES2141085T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Slot Machines And Peripheral Devices (AREA)

Abstract

ESTA INVENCION APORTA NUEVOS ANALOGOS DEL FACTOR DE LIBERACION DE LA HORMONA DEL CRECIMIENTO (FLC). LAS VERSIONES MODIFICADAS QUIMICAMENTE DE ESTAS MOLECULAS TAMBIEN SE PROPONE COMO COMPUESTOS DE ADN QUE CODIFICAN ANALOGOS DE FLC. ALGUNOS DE LOS COMPUESTOS DE POLIPEPTIDOS PUEDEN SER OBTENIDOS EN GRANDES PROPORCIONES MEDIANTE LA PRODUCCION DE LOS COMPUESTOS EN E. COLI. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS Y METODOS PARA EL ESTIMULO DE LA LIBERACION DE LA HORMONA DEL CRECIMIENTO.
ES91303507T 1990-04-24 1991-04-19 Analogos del factor liberador de la hormona del crecimiento. Expired - Lifetime ES2141085T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51373090A 1990-04-24 1990-04-24
US58732390A 1990-09-24 1990-09-24

Publications (1)

Publication Number Publication Date
ES2141085T3 true ES2141085T3 (es) 2000-03-16

Family

ID=27057991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91303507T Expired - Lifetime ES2141085T3 (es) 1990-04-24 1991-04-19 Analogos del factor liberador de la hormona del crecimiento.

Country Status (18)

Country Link
EP (1) EP0454367B1 (es)
JP (1) JPH04305598A (es)
KR (1) KR910018546A (es)
CN (1) CN1066345C (es)
AT (1) ATE186570T1 (es)
AU (1) AU643773B2 (es)
CA (1) CA2040649A1 (es)
DE (1) DE69131771T2 (es)
DK (1) DK0454367T3 (es)
ES (1) ES2141085T3 (es)
FI (1) FI911961A7 (es)
GR (1) GR3032384T3 (es)
HU (1) HUT60634A (es)
IE (1) IE911358A1 (es)
IL (1) IL97885A0 (es)
NO (1) NO911609L (es)
NZ (1) NZ237857A (es)
PT (1) PT97414A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973114A (en) * 1992-06-23 1999-10-26 The University Of Virginia Patent Foundation Isolation and characterization of the growth hormone releasing hormone receptor
BR112013027150A2 (pt) * 2011-04-21 2017-06-06 Theratechnologies Inc thera
CN109180800B (zh) * 2018-08-01 2019-07-12 广东药科大学 新型生长激素释放激素类似肽二聚体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728609A (en) 1983-01-10 1988-03-01 Hoffmann-La-Roche Inc. Recombinant growth hormone releasing factor
US4617149A (en) 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
IT1234977B (it) 1985-03-22 1992-06-09 Serono Ist Farm Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
US4734399A (en) 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
PT83613B (en) 1985-10-28 1988-11-21 Lilly Co Eli Process for the selective chemical removal of a protein amino-terminal residue
IL86102A (en) * 1987-05-11 1994-04-12 Univ Tulane Alkylated growth hormone-releasing peptides and use thereof
IL91771A0 (en) * 1988-09-30 1990-06-10 Lilly Co Eli Increased expression of small molecular weight recombinant proteins

Also Published As

Publication number Publication date
GR3032384T3 (en) 2000-04-27
DE69131771D1 (de) 1999-12-16
PT97414A (pt) 1992-01-31
IL97885A0 (en) 1992-06-21
EP0454367A2 (en) 1991-10-30
AU7525091A (en) 1991-11-07
NO911609L (no) 1991-10-25
EP0454367B1 (en) 1999-11-10
FI911961L (fi) 1991-10-25
EP0454367A3 (en) 1992-07-29
NZ237857A (en) 1992-05-26
AU643773B2 (en) 1993-11-25
FI911961A0 (fi) 1991-04-23
CA2040649A1 (en) 1991-10-25
DE69131771T2 (de) 2000-04-06
ATE186570T1 (de) 1999-11-15
FI911961A7 (fi) 1991-10-25
JPH04305598A (ja) 1992-10-28
HU911358D0 (en) 1991-10-28
KR910018546A (ko) 1991-11-30
CN1057784A (zh) 1992-01-15
IE911358A1 (en) 1991-11-06
DK0454367T3 (da) 2000-03-27
NO911609D0 (no) 1991-04-23
CN1066345C (zh) 2001-05-30
HUT60634A (en) 1992-10-28

Similar Documents

Publication Publication Date Title
ES2169095T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen.
UY23561A1 (es) Procedimiento para la preparacion de tnf-muteinas
ES2132066T3 (es) Procedimiento para la produccion de proteina biologicamente activa (v.g. tfg).
MX9302475A (es) Polipeptido de origen no natural que tiene la actividad del factor recombinante de estimulacion del receptor neu y proceso para la produccion del mis mo.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ES2037753T3 (es) Compuestos heterociclicos y su preparacion y uso.
MX9307229A (es) Factor de estimulacion de progenitores de celulas b, proceso para su obtencion y composiciones farmaceuticas que lo contienen.
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
NO165804C (no) Veksthormon-frigjoerende peptider og anvendelse derav.
AR013529A1 (es) Rantes amino-terminalmente truncado, moleculas de adn, vector de expresion, celula huesped, proceso recombinante para prepararlo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende.
ES8707243A1 (es) Un procedimiento para preparar derivados de tienopiridona
ES2061456T3 (es) Compuestos de quinoxalina y preparacion y uso de los mismos.
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2112847T3 (es) Somatotropina con alteraciones en la region de la alfa-helice 1 y combinaciones con otras mutaciones.
DE3676640D1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
DE3243358A1 (de) Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose
DK0454367T3 (da) Væksthormon-releasing faktor-analoger
ES2052622T3 (es) Derivados de benzodioxol, compuestos que los comprenden y utilizacion de los mismos para la fabricacion de medicamentos.
AR034853A1 (es) Secuencia de acido nucleico sintetico que codifica una alfa-galactosidasa, vector y celula que la comprenden, metodo para producir alfa-galactosidasa, metodo para prepararla, composicion farmaceutica que comprende dicha secuencia y su uso para preparar esta ultima
ES2059717T3 (es) Nuevos polipeptidos y adn codante para estos.
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES2010179A4 (es) Lactogeno placental bovino
DE69027967D1 (de) Proteine, die die expression von vertebraten-mhc-klasse-ii-genen regulieren, dafür kodierende dna-sequenzen und pharmazeutische zusammensetzungen
ATE291087T1 (de) Il-6 mutein

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454367

Country of ref document: ES